Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

NCT03927391 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms, Castration-Resistant

Interventions

DRUG: Enzalutamide

Sponsor

Radboud University Medical Center